Aims and scope
Inflammation and Regeneration is the official international journal of the Japanese Society of Inflammation and Regeneration (JSIR). This journal provides an open access forum which covers a wide range of scientific topics in the research field of basic and clinical regenerative medicine. Inflammation research and regenerative medicine are tightly linked research areas in life sciences and their significance in translational research is rapidly increasing. From this aspect, this journal encourages the submission of manuscripts whose scope bridges these fields of research.
Inflammation and Regeneration publishes papers in the following categories: research article, note, rapid communication, case report, review and clinical drug evaluation.
All articles published by Inflammation and Regeneration are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Inflammation and Regeneration you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
The publication costs for Inflammation and Regeneration are covered by the Japanese Society of Inflammation and Regeneration for articles submitted before 1 January 2018, so authors do not need to pay an article-processing charge for each article accepted for publication.
All articles published in Inflammation and Regeneration are included in:
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
We are working closely with relevant indexing services including PubMed Central and Web of Science (Thomson Reuters) to ensure that articles published in Inflammation and Regeneration will be available in their databases when appropriate.
Inflammation and Regeneration operates using a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
All submitted manuscripts are evaluated by the Editor-in-Chief and suitable manuscripts proceed to peer review, being assigned to a handling editor where appropriate. Comments are sought from at least two reviewers. Based on the reviews, the Editor-in-Chief or handling editor rejects, accepts or requests revisions of the manuscript.
All manuscripts submitted to Inflammation and Regeneration should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Citing articles in Inflammation and Regeneration
Articles in Inflammation and Regeneration should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Inflamm Regen [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Inflamm Regen 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.
Why publish your article in Inflammation and Regeneration
Inflammation and Regeneration's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Inflammation and Regeneration offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in Inflammation and Regeneration gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Inflammation and Regeneration are included in article alerts and regular email updates. Some may be highlighted on Inflammation and Regeneration’s pages and on the BioMed Central homepage.
In addition, articles published in Inflammation and Regeneration may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Inflammation and Regeneration. A list of articles recently press-released by journals published by BioMed Central is available here.
As an author of an article published in Inflammation and Regeneration you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.